Galapagos Adr Representing Nv

Galapagos NV, a Belgium‑based biotech, develops point‑of‑care CAR‑T therapies (GLPG5101–GLPG5301) for oncology and immunology, alongside innovative small‑molecule drugs, partnered with Gilead and AbbVie.

Headquarters: Belgium (BEL)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical Practices

Employees: 704
HQ: Mechelen

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
GXEA	Galapagos Adr Representing Nv Cap: 1.9B	EQUITY	FRA	EUR	US36315X1019	Active	📈